Up To 50 SAR OFF Your First Order Use Code : APP50 | Get Free Delivery With No Minimum Order

Frequently bought together
AVOMACK SOLUTION 15ML
- Sku : I-014647
Key features
AVOMACK Solution 15 mL is a cutaneous solution containing salicylic acid 16.7% (w/w) and lactic acid 16.7% (w/w). Salicylic acid acts as a keratolytic by solubilizing intercellular cement and reducing corneocyte cohesion, while lactic acid (an AHA) further decreases cohesion and alters keratinization to promote softening and desquamation of hyperkeratotic tissue. It is indicated for the topical treatment and removal of warts, corns and calluses. Supplied as a cutaneous solution in a 15 mL pack.- Brand: AVOMACK
- Active Ingredient: SALICYLIC ACID 16.7% (W/W), LACTIC ACID 16.7% (W/W)
- Strength: 16.7,16.7% (W/W)
- Dosage Form: Cutaneous solution
- Pack Size: 10 ml
- Route: Topical
- Prescription Status: Prescription
- Therapeutic Class: Dermatological
- Drug Class: Topical keratolytic (salicylic acid + lactic acid/AHA combination).
- Manufacturer: (Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd
- Country of Origin: Saudi Arabia
- SFDA Registration No.: 2509245949
- Shelf Life: 24 months
- Storage: store below 30°c
- Skin Condition: Warts/Hyperkeratosis
Frequently bought together
Indications
Approved Uses
Topical treatment/removal of warts, corns, and calluses (hyperkeratotic lesions).
Dosage & Administration
Dosing by Condition
Warts/corns/calluses: apply a small amount to the lesion only once daily (some regimens allow up to twice daily if tolerated) after soaking and gentle paring; continue until resolution-typically up to 12 weeks for warts, and usually shorter for corns/calluses (often 1-2 weeks, but may require longer depending on thickness/response).
Initial Dose
Apply 1-2 drops to the affected lesion once daily
Maintenance Dose
Apply 1-2 drops once or twice daily to the affected area
How to Take
For external use on warts/corns/calluses only: soak the affected area in warm water for ~5 minutes, dry well, gently pare/rub thickened surface (pumice/emery board), protect surrounding normal skin (e.g., petroleum jelly) if needed, then apply a small amount of solution to the lesion only and allow to dry; repeat once daily or as directed by the prescriber.
Side Effects
Common Side Effects
Application-site irritation (burning/stinging), redness/erythema, peeling/desquamation, dryness, and itching.
Safety & Warnings
Warnings & Precautions
External use only; flammable-keep away from heat/flame; avoid eyes, face, genitals, and mucous membranes; protect surrounding healthy skin and apply only to the lesion; do not use on moles/birthmarks/hairy warts; avoid use on broken/irritated/infected skin; use with caution and medical supervision in diabetes or poor circulation; avoid large-area/occlusive use (especially in children) due to salicylate toxicity risk; discontinue if severe irritation or infection develops
Driving Warning
Safe
Drug Interactions
Food Interaction
Not applicable (no clinically relevant food interactions with topical cutaneous solution).
Storage & Patient Advice
Patient Counseling
Apply carefully to the lesion only (wart/corn/callus), avoiding healthy skin; consider protecting surrounding skin with petrolatum; allow to dry before covering/clothing. Avoid use on face, genitals, mucous membranes, and on moles/birthmarks. Do not apply to broken/irritated skin or large areas; avoid occlusion unless directed. Flammable preparation: keep away from heat/open flame and do not smoke during/after application until dry. If significant irritation/chemical burn or signs of infection occur, stop and seek medical advice; improvement may take several weeks with consistent use.
Monitoring Requirements
No routine labs required; monitor for excessive local irritation/chemical burn and stop/seek advice if severe; if used on large areas/under occlusion or in high-risk patients, monitor for symptoms of salicylate toxicity (e.g., tinnitus, dizziness, nausea).
Pharmacology
Mechanism of Action
Salicylic acid is a keratolytic that decreases corneocyte cohesion by solubilizing intercellular cement, promoting desquamation; lactic acid (AHA) also reduces corneocyte cohesion and alters keratinization, enhancing shedding/softening of hyperkeratotic tissue.
Onset of Action
Softening/visible improvement often within 1-2 weeks; complete clearance may take 6-12 weeks for warts (often faster for corns/calluses).
Duration of Effect
Effect is dependent on continued regular application; keratolysis is not sustained after stopping.
Product Information
Available Dosage Forms
Cutaneous solution.
Composition per Dose
Per ml of cutaneous solution: Salicylic acid 16.7% (w/w) + Lactic acid 16.7% (w/w) in a flexible collodion base
Skin Condition
Warts/Hyperkeratosis
Legal Disclaimer - Al Mujtama Pharmacy The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment. Al Mujtama Pharmacy assumes no legal or medical liability for: Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist Any discrepancy between the information provided and the product's package insert or SFDA guidelines Any misuse of medication resulting from personal interpretation of the content displayed Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication. By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation. Your health is a trust - always consult your doctor first.-1744229570.gif)












